Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS. The FDA has approved Omvoh for the treatment of moderately to ...
Objective Inflammatory bowel disease (IBD) is a multifactorial immune-mediated inflammatory disease of the intestine, comprising Crohn’s disease and ulcerative colitis. By characterising metabolites ...